Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2451 of 6351
-
Bone drug switch: can alendronate and zoledronate keep bones strong after denosumab?
Disease control CompletedThis study intends to investigate whether Alendronate and Zoledronate can prevent bone mineral density loss after long-term treatment with Denosumab.
Phase 4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Does a nutrition expert team ease the burden on mothers of kids with food allergies?
Symptom relief CompletedFood allergy (FA) derives from an abnormal immunological response to dietary antigens. On the basis of the immunological mechanism, FA are divided into the following forms: IgE-mediated, non-IgE-mediated and mixed. Prevalence, persistence and severity of pediatric FA have signifi…
Sponsor: Federico II University • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Exercise boosts quality of life in cancer patients, study finds
Symptom relief OngoingThis prospective observational cohort study evaluates a community-based supervised exercise oncology program delivered in real-world settings in Madrid, Spain. The program is designed for adults with a cancer diagnosis across the cancer continuum, including survivors, patients un…
Sponsor: University of Castilla-La Mancha • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
A gene test might curb drinking in east asians
Knowledge-focused CompletedAlcohol intolerance is common in East Asian populations and is strongly influenced by the rs671 variant in the ALDH2 gene. This study examined the associations of ALDH2 genotype with drinking behavior and alcohol-related reactions among Taiwanese university students. Participants…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New online tool helps rural parents struggling with opioids
Prevention CompletedOpioid use is rising at unprecedented levels and has reached epidemic proportions in some areas of the country, particularly rural areas. Although research on the detrimental effects of opioid use on parenting and children is relatively new, it is clear that parents with opioid u…
Sponsor: University of Oregon • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New eczema ointment shows promise in early trial
Symptom relief CompletedThis is a Phase I/II Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis.
Phase 1/2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Symptom relief
Last updated Jun 26, 2026 19:16 UTC
-
A light switch for better sleep? Alzheimer's trial tests wireless circadian lighting
Symptom relief CompletedTo test the effect of a tailored lighting intervention controlled by the Readings At Desk (RAD) controller on sleep and mood in Alzheimer's disease participants.
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Stopped earlyIn this study, people with mesothelin-expressing advanced or metastatic solid tumors will receive TAK-103 with their white blood cells. The main aims of this study are to check if the participants get any side effects from treatment with TAK-103 and to check how much TAK-103 part…
Phase 1 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Second look inside the kidney: could repeat biopsies save lupus Patients' kidneys?
Knowledge-focused Recruiting nowLupus nephritis (LN) is one of the most severe complications of systemic lupus erythematosus (SLE). Among people living with SLE, 35-60% will develop LN during the course of the disease. This complication is one of the factors that contribute to deterioration of the renal functio…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:53 UTC
-
Diabetes drug may fight heart scarring in High-Risk patients
Disease control CompletedRecently, large clinical intervention studies have demonstrated the cardiovascular protective effects on of sodium-glucose cotransporter 2 inhibitors (SGLT2i) such as empagliflozin, dapagliflozin, and canagliflozin in reduction of cardiovascular and all-cause mortality, coinciden…
Phase 4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Stitch showdown: can a simple change prevent hernias after liver surgery?
Prevention Recruiting nowThis clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tumor surgery. This study may help researchers learn if one technique can lower the chances of developing a hole in the wal…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:38 UTC
-
Scientists probe immune chaos after sepsis and trauma
Knowledge-focused Recruiting nowAdverse outcomes in surgical sepsis patients are secondary to dysregulated emergency myelopoiesis, and expansion of myeloid-derived suppressor cells. Here we propose to determine the underlying mechanisms behind the increased expansion of these leukocyte populations and the under…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
New MRI method could spot reversible dementia more accurately
Knowledge-focused CompletedNormal pressure hydrocephalus (NPH) can cause a type of dementia. However, this type of dementia is the only one that is reversible. To treat this dementia it is necessary to evacuate the accumulation of CSF from the brain to another body cavity using a device called a shunt. But…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Could a common diabetes drug help older heart failure patients move better?
Symptom relief CompletedMet-PEF will be a randomized, double-blind, placebo-controlled trial to examine the effects of 20 weeks of 1500 mg/day of metformin on physical function, quality of life (QOL), microbiome diversity, leaky gut, and systemic inflammation in patients with 86 older patients with hear…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New 3-session therapy aims to curb aggression in veterans with PTSD
Symptom relief Recruiting nowPTSD is one of the most prevalent mental health conditions affecting Veterans who have served since 9/11. Veterans with posttraumatic stress disorder (PTSD) report difficulty controlling impulsive aggression (IA). An inability to manage one's emotions (emotion dysregulation) is a…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Can a common mental health drug beat standard care for cancer appetite loss?
Symptom relief OngoingThis phase III trial compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with cancer that has spread to other places in the body (advanced). Olanzapine may stimulate and increase appetite. This study aims to find out if olanzapine …
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
What stops families from enrolling in child cancer trials?
Knowledge-focused CompletedExplore factors involved in decision making for patients with new or recurrent CNS tumors and their families surrounding treatment planning and clinical trial enrollment.
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Short therapy sessions could ease anxiety for veterans
Symptom relief CompletedThis 4-year study will examine the value of a type of a brief cognitive behavioral therapy treatment for Veterans with anxiety and worry. This treatment will be delivered either in-person, or by video telehealth to the Veteran's home. The treatment will be delivered by providers …
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Nerve block shot could silence stubborn coughs
Symptom relief Recruiting nowThe purpose of this study is to evaluate if office-based injection of a local anesthetic/steroid combination at the area of one superior laryngeal nerve can decrease cough frequency and alleviate symptoms of chronic cough in patients with neurogenic cough.
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
NIH launches major study to unravel mysteries of long COVID recovery
Knowledge-focused Recruiting nowBackground: People who get COVID-19 have a wide range of symptoms. They also recover from COVID-19 in different ways. In this study, researchers will use survey data to describe the different ways people experience and recover from COVID-19. They will also use the data to help c…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 10, 2026 09:00 UTC